Related Experiment Video
Updated: May 17, 2026

Multi-enzyme Screening Using a High-throughput Genetic Enzyme Screening System
Published on: August 8, 2016
Screening reactive metabolites bioactivated by multiple enzyme pathways using a multiplexed microfluidic system
Dhanuka P Wasalathanthri1, Ronaldo C Faria, Spundana Malla
1Department of Chemistry, University of Connecticut, Storrs, Connecticut 06269, USA.
A new microfluidic device screens reactive metabolites from drug metabolism, measuring DNA damage from oxidative and bioconjugation enzymes. This platform aids in predicting chemical genotoxicity by mimicking human metabolism.
Area of Science:
- Analytical Chemistry
- Biotechnology
- Toxicology
Background:
- Assessing reactive metabolites is crucial for understanding drug metabolism and predicting genotoxicity.
- Existing methods for detecting reactive metabolites can be time-consuming and complex.
- Mimicking multi-enzyme human drug metabolism pathways is essential for accurate toxicity assessments.
Purpose of the Study:
- To develop and validate a multiplexed, microfluidic platform for detecting reactive metabolites.
- To assess the platform's performance in mimicking human drug metabolism and identifying genotoxic compounds.
- To enable high-throughput screening of enzyme-mediated reactions and DNA damage.
Main Methods:
- A microfluidic device with screen-printed carbon arrays coated with DNA and a ruthenium-polyvinylpyridine (RuPVP) catalyst.
- Integration of multiple enzyme sources: human liver microsomes (HLM), cytochrome P450 (cyt P450) 1B1 supersomes, microsomal epoxide hydrolase (EH), human S9 liver fractions (Hs9), and N-acetyltransferase (NAT).
- Detection of reactive metabolites via DNA adduct formation and measurement using square wave voltammetry (SWV) with RuPVP catalyst.
Main Results:
- The platform successfully detected reactive metabolites from compounds requiring metabolic activation for genotoxicity.
- Metabolism of benzo[a]pyrene (B[a]P) showed enhanced DNA damage when epoxide hydrolase was included with cyt P450s.
- DNA damage rates for arylamines correlated better with rodent genotoxicity metrics when both oxidative and conjugative enzymes were present.
Conclusions:
- The developed microfluidic device is a versatile tool for screening reactive metabolites and assessing potential genotoxicity.
- The platform effectively mimics complex human drug metabolism pathways involving multiple enzymes.
- This technology offers a rapid and efficient method for evaluating chemical safety and predicting drug-induced toxicity.
More Related Videos
09:49Fast Enzymatic Processing of Proteins for MS Detection with a Flow-through Microreactor
Published on: April 6, 2016
14:43Microfluidic On-chip Capture-cycloaddition Reaction to Reversibly Immobilize Small Molecules or Multi-component Structures for Biosensor Applications
Published on: September 23, 2013